Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
Clinical trial NCT04289779 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04289779
- Sponsor
- Deepak Kilari
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-21
- Primary completion
- 2025-06-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.